Emtricitabine + Tenofovir
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Emtricitabine
emtricitabine - Tenofovir
tenofovir
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| DESCOVY 200 mg/10 mg, comprime pelliculéFR | 200 mg | GILEAD SCIENCES IRELAND UC (IRLANDE) |
| MOVITREMMX | — | Sandoz, S.A. de C.V. |
| LUVIREN-PROMX | — | Hetero Labs Limited |
| TREWIXMX | — | Laboratorios Corne, S.A. de C.V. |
| EZITABRITMX | — | Protein, S.A. de C.V. |
| EMTRICITABINE TENOFOVIR DISOPROXIL MYLAN 200 mg/245 mg, comprimé pelliculéFR | 200 mg | MYLAN PHARMACEUTICALS (IRLANDE) |
| EMTRICITABINE/TENOFOVIR DISOPROXIL ACCORD 200 mg/245 mg, comprimé pelliculéFR | 200 mg / 300 mg | ACCORD HEALTHCARE FRANCE |
| EMTRICITABINE/TENOFOVIR DISOPROXIL ARROW 200 mg/245 mg, comprimé pelliculéFR | 200 mg / 300 mg | ARROW GENERIQUES |
| EMTRICITABINE/TENOFOVIR DISOPROXIL BIOGARAN 200 mg/245 mg, comprimé pelliculéFR | 300.6 mg / 200 mg | BIOGARAN |
| EMTRICITABINE/TENOFOVIR DISOPROXIL EG 200 mg/245 mg, comprimé pelliculéFR | 300.6 mg / 200 mg | EG LABO - LABORATOIRES EUROGENERICS |
| EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200 mg/245 mg, comprimé pelliculéFR | 300.7 mg / 200 mg | KRKA (SLOVENIE) |
| EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA D.D. 200 mg/245 mg, comprimé pelliculéFR | 300.7 mg / 200 mg | KRKA (SLOVENIE) |
| EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 200 mg/245 mg, comprimé pelliculéFR | 200 mg / 291.22 mg | TEVA SANTE |
| EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA 200 mg/245 mg, comprimé pelliculéFR | 200 mg / 291.5 mg | ZENTIVA (REPUBLIQUE TCHEQUE) |
| EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA LAB 200 mg/245 mg, comprimé pelliculéFR | 200 mg / 300 mg | ZENTIVA FRANCE |
| EMTRICITABINE/TENOFOVIR DISOPROXIL ZYDUS 200 mg/245mg, comprimé pelliculéFR | 200 mg / 300 mg | ZYDUS FRANCE |
| TRUVADA 200 mg/245 mg, comprimé pelliculéFR | 200 mg / 300 mg | GILEAD SCIENCES IRELAND UC (IRLANDE) |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.